Study confirms beneficial effect of Tri-Low full spectrum Amla extract upon dyslipidemia
A newly published study demonstrates the efficacy and safety of Tri-Low® full extract of amla (Phyllanthus emblica), the Indian gooseberry, in alleviating dyslipidemia, a leading contributing risk factor to the development of atherosclerosis.
The amla extract has shown significant potential in reducing total cholesterol and triglyceride levels and in stimulating a more favorable balance of lipid ratios. These results confirm Tri-Low’s functionality as a superior, clean-label cardiac health supplement.